A Dose Ranging Study of the Effect of Ruxolitinib Phosphate Cream When Applied to Participants With Plaque Psoriasis
Public ClinicalTrials.gov record NCT00778700. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Randomized, Vehicle-Controlled Dose Ranging Study of the Effect of INCB018424 Phosphate Cream When Applied to Patients With Plaque Psoriasis
Study identification
- NCT ID
- NCT00778700
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Incyte Corporation
- Industry
- Enrollment
- 199 participants
Conditions and interventions
Conditions
Interventions
- Placebo Cream Other
- Ruxolitinib Phosphate Drug
Other · Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 27, 2008
- Primary completion
- Jun 25, 2009
- Completion
- Jun 25, 2009
- Last update posted
- Feb 8, 2022
2008 – 2009
United States locations
- U.S. sites
- 28
- U.S. states
- 19
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Hot Springs | Arkansas | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | Santa Monica | California | — | — |
| Not listed | Vallejo | California | — | — |
| Not listed | New Haven | Connecticut | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Ormond Beach | Florida | — | — |
| Not listed | Naperville | Illinois | — | — |
| Not listed | Wheaton | Illinois | — | — |
| Not listed | Evansville | Indiana | — | — |
| Not listed | South Bend | Indiana | — | — |
| Not listed | Boston | Massachusetts | — | — |
| Not listed | Clinton Township | Michigan | — | — |
| Not listed | Fridley | Minnesota | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Albuquerque | New Mexico | — | — |
| Not listed | Rochester | New York | — | — |
| Not listed | Norman | Oklahoma | — | — |
| Not listed | Simpsonville | South Carolina | — | — |
| Not listed | Austin | Texas | — | — |
| Not listed | College Station | Texas | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Salt Lake City | Utah | — | — |
| Not listed | Norfolk | Virginia | — | — |
| Not listed | Walla Walla | Washington | — | — |
| Not listed | Madison | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00778700, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 8, 2022 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00778700 live on ClinicalTrials.gov.